CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,503 shares at $16.94 ($59,341)
- 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 3,477 shares at $16.94 ($58,900)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,326 shares at $16.94 ($22,462)
- 4 Open-market sale CEO sold 11,427 shares at $16.94 ($193,573)
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CEO sold 26,574 shares at $17.87 ($474,877)
- 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 2,568 shares at $17.87 ($45,890)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,790 shares at $17.87 ($31,987)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 2,716 shares at $17.87 ($48,535)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 5,140 shares at $17.90 ($92,006)
- 4 Open-market sale CEO sold 17,714 shares at $17.90 ($317,081)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 5,434 shares at $17.90 ($97,269)
- 8-K Event Other events
- 10-K Report Annual Report
Page 9 of 70 · 1,382 filings